SCHEDULE: Viking Global Discloses 5.02% Stake in Roivant Sciences
Schedule 13G
Viking Global Investors LP and its affiliates, along with key executives, reported a collective beneficial ownership of 5.02% in Roivant Sciences Ltd. common shares.
Summary
- Viking Global Investors LP, along with its affiliated entities and executive committee members O. Andreas Halvorsen, David C. Ott, and Rose S. Shabet, collectively reported beneficial ownership of 34,237,779 common shares of Roivant Sciences Ltd.
- This aggregate ownership represents 5.02% of Roivant Sciences Ltd.'s common shares outstanding.
- The percentage is based on 682,229,832 common shares outstanding as of June 30, 2025, as reported by Roivant Sciences Ltd. in its Form 10-Q filed on August 11, 2025.
- All reported shares are held with shared voting and shared dispositive power among the reporting persons.
- The filing is an Amendment No. 5 to a previously filed Schedule 13G, indicating an update to an existing passive investment disclosure.
Sentiment
Score: 5
Explanation: This is a routine ownership disclosure (Schedule 13G) and does not contain performance or strategic information to assess sentiment beyond neutrality.
Key Dates
| Date | Description |
|---|---|
| 2025-06-30 | Date of event requiring the filing of this statement, reflecting beneficial ownership. |
| 2025-08-11 | Date Roivant Sciences Ltd. reported 682,229,832 common shares outstanding in its Form 10-Q. |
| 2025-08-14 | Date of filing of this Schedule 13G Amendment No. 5. |
Keywords
Roivant Sciences, Viking Global Investors, Schedule 13G, beneficial ownership, institutional investment, common shares, passive investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.